Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.00
Bid: 13.50
Ask: 14.50
Change: 0.00 (0.00%)
Spread: 1.00 (7.407%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.00
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks make headway thanks to retailers

Thu, 05th Jan 2023 16:56

(Alliance News) - Stock prices in London closed higher, buoyed by optimism from strong retail updates, and shaking off hawkishness from the US Federal Reserve.

The FTSE 100 index closed up 48.26 points, 0.6%, at 7,633.45. The FTSE 250 ended up 72.36, 0.4%, at 19,463.43, and the AIM All-Share closed down just 0.19 of a point at 843.74.

The Cboe UK 100 ended up 0.8% at 764.81, the Cboe UK 250 closed up 0.9% at 16,978.11, and the Cboe Small Companies ended up 0.1% at 13,622.94.

US private employment rose by 235,000 jobs in December, according to figures from payroll firm ADP on Thursday.

The rise in private employment came well above market consensus, as cited by FXStreet, which had expected 150,000 jobs to be added.

In November, US private employers added 127,000 jobs.

December's increase was led by consumer-facing service industries, ADP said, with hiring strong across small and medium establishments. Large establishments, defined as companies with more than 500 employees, saw a drop in employment of 151,000 jobs.

Separately, the US Department of Labor reported that initial unemployment claims in the US fell in the week ending December 31.

The advance figure for seasonally adjusted initial claims was 204,000, representing a decrease of 19,000 from the previous week's figures of 223,000. Last week's figure was downwardly revised from 225,000.

The latest figures came below market expectations of 225,000.

The stronger-than-expected jobs print reignited fears over further hawkishness from the US Federal Reserve.

In minutes from its December meeting released on Thursday, the Federal Open Market Committee had said it was looking for further evidence that inflation was cooling. It highlighted its concern that the labour market remains "very tight", which is putting upward pressure on wages and prices.

In the US, the Dow Jones Industrial Average was down 1.1%, the S&P 500 was down 1.1% and Nasdaq Composite was 1.4% lower.

"Today's stronger employment data has therefore reduced fears about a downturn in employment and has raised worries that wage inflation could accelerate further and thus provide a major source of risk in the inflation outlook. Accordingly, traders have pushed up their expectations for the terminal interest rates in the US," explained Fawad Razaqzada, City Index and Forex.com market analyst.

The dollar firmed after the jobs data.

The pound was quoted at USD1.1890 at the close on Thursday in London, sharply lower compared to USD1.2054 at the close on Wednesday. The euro stood at USD1.0525, lower against USD1.0598. Against the yen, the dollar was trading at JPY133.89, sharply higher compared to JPY131.87.

In European equities on Thursday, the CAC 40 in Paris ended down 0.2%, while the DAX 40 in Frankfurt ended down 0.4%.

In the FTSE 100, Standard Chartered jumped 8.2%.

This follows a release from First Abu Dhabi Bank, which said it is no longer evaluating a takeover offer for FTSE 100-listed Asian-focused bank Standard Chartered PLC.

First Abu Dhabi Bank is a bank in the United Arab Emirates. It said it had previously been at the very early stages of evaluating a possible offer for Standard Chartered, but is no longer doing so.

Fellow Asia-focused lender, HSBC, also performed well, as Jefferies raised the stock to 'buy' from 'hold'. It rose 4.1%.

The investment banking and capital markets firm said HSBC is positively geared to the re-opening of the Chinese market as Covid-19 restrictions ease, along with the re-opening of the Hong Kong and mainland China border on Sunday this week.

It was also a strong day for bluechip retailers, as the first of the post-Christmas updates came in.

Clothing retailer Next rose 7.4%.

For the year ending in January 2023, Next increased its 2022 pretax profit guidance to GBP860 million, from GBP840 million. This would represent growth of 4.5% against the year prior, if achieved.

In the six months to December 30, Next said full price sales were up 2.2% against the previous year. In the three months to December 30, full price sales were up 4.7% against the year prior.

Clothing peers JD Sports, and Frasers were up 3.4% and 3.4%, respectively, in a positive read-across. Smallcap Superdry gained 8.6%.

B&M rose 0.5%.

The budget retailer said revenue in the 13 weeks to December 24 was up 12% to GBP1.57 billion from GBP1.40 billion a year prior, despite a challenging macroeconomic environment.

As a result, full-year adjusted earnings before interest, tax, depreciation and amortisation are now expected between GBP560 million to GBP580 million, coming above current analyst outlook consensus of GBP557 million.

The anticipated adjusted Ebitda would be a drop of at least 6.3% from GBP619 million in financial year 2022, however.

"B&M appeals to people who want to trade down from more expensive retailers, showing that the value proposition from a pricing perspective is a winning model in the current environment," AJ Bell's Russ Mould commented.

In the FTSE 250, Greggs was down 1.0%. The bakery chain reported strong double-digit growth in fourth quarter sales, despite the impact of adverse weather and rail strikes, as 2022 drew to a close.

In 2022, total sales were up 23% to GBP1.51 billion, from GBP1.23 billion the year prior. Like-for-like sales for 2022 were up 18%.

"Next, B&M and Greggs are united by having a presence on retail parks where business has been better than expected in general. Widespread train strikes will have prevented a lot of people from going to city centre shops, which means retail parks with their plentiful parking spaces have been the preferred alternative shopping destination," said Mould.

Wizzair added 13%, and easyJet rose 6.0%, after a positive update from airline peer Ryanair late Wednesday.

The Dublin-based low-cost airline said that it expects a stronger-than-expected third-quarter performance, due to strong pent-up travel demand over the holiday season.

The firm now expects full-year post-tax profit in the range of EUR1.33 billion to EUR1.43 billion, up from an initial forecast of EUR1 billion to EUR1.2 billion.

However, the budget airline noted in a statement that the reassessment was "heavily dependent" on avoiding further fallout from "adverse events" such as Covid or the ongoing war in Ukraine.

Meanwhile on AIM, Angle plunged 37%.

The Surrey, England-based medical diagnostics company said it expects "growth" in 2023, albeit significantly lower than market estimates, as it anticipates its operating loss to widen.

The Surrey, England-based medical diagnostics company noted it is on track to deliver anticipated cost savings of GBP2.6 million in 2023 and GBP4.0 million per year after that.

Describing 2022 as a "breakthrough year" with the first US Food & Drug Administration product clearance, Angle anticipates revenue to be just above GBP1 million, similar to GBP1.0 million posted for 2021. It estimates an operating loss of GBP22 million, in line with expectations and widened by 28% from GBP17.2 million in 2021.

Brent oil was quoted at USD78.48 a barrel at the London equities close Thursday from USD78.07 late Wednesday, while Gold fetched USD1,828.35 an ounce, down sharply from USD1,857.48.

In the global economic calendar, there's a Japan services PMI overnight, and then there will be German retail trade, manufacturing orders and manufacturing turnover at 0700 GMT.

There's the latest UK construction PMI at 0930 GMT, followed shortly after by EU data, including a flash inflation estimate, retail trade figures, and economic sentiment at 1000 GMT. The ISM US services PMI will come later in the day.

On the corporate side, there's a trading update from ten-pin bowling operator Ten Entertainment.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
28 Feb 2019 13:30

Angle Enrolls First Patients In Ovarian Cancer Study

LONDON (Alliance News) - Angle PLC on Thursday said it has enrolled the first patients in an ovarian cancer verification study, after receiving ethics approval.The study will be divided a a

Read more
25 Feb 2019 10:51

Angle client demonstrates new use for 'Parsortix' system

(Sharecast News) - Liquid biopsy company Angle said on Monday that one of its leading customers, the Disseminated Cancer Cell Network (DCCNet) in Duesseldorf, has published new results in a peer-reviewed journal of work done to harvest circulating tumor cells (CTCs) from diagnostic leukapheresis (DLA) samples.

Read more
11 Feb 2019 11:35

Angle's 'Parsortix' used in new groundbreaking cancer research

(Sharecast News) - Liquid biopsy company Angle announced on Monday that its 'Parsortix' system had been utilised in further "groundbreaking" cancer research into CTC clusters, reportedly demonstrating that the patient's own immune cells (neutrophils) could actively help the process of metastasis by which the cancer spread.

Read more
31 Jan 2019 12:04

Angle Reports Widened Interim Loss On Higher Operating Costs

LONDON (Alliance News) - Angle PLC on Thursday reported a widened interim loss on an increase operating costs.In the six months to October 31, the tumour cell researcher said its pretax to

Read more
24 Jan 2019 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 25 January BonmarcheTrading Statement AG BarrTrading GroupQ3 Smaller

Read more
10 Jan 2019 17:05

Angle Shares Jump As Parsortix System Used In New Cancer Treatment

LONDON (Alliance News) - Angle PLC shares spiked late Thursday afternoon after the company said its Partsortix system will be used in "ground-breaking" new cancer research.Shares

Read more
5 Nov 2018 12:11

ANGLE To Acquire Remaining Stake In US Subsidiary For GBP467,500 (ALLISS)

LONDON (Alliance News) - Liquid biopsy company ANGLE PLC said on Monday it has agreed to acquire the remaining shares in US subsidiary ANGLE North America Inc it does not own from Parsotix Georgi

Read more
1 Nov 2018 14:09

Angle Appoints Cancer Diagnostic Firm Chief As Non-Executive Director

LONDON (Alliance News) - Biopsy company Angle PLC said Thursday it has appointed the President of Euronext-listed cancer diagnostics firm MDxHealth to its board.Jan Groen joins the board of

Read more
29 Oct 2018 11:27

Angle Pilot Study Shows Promise Of Parsortix In Prenatal Testing

LONDON (Alliance News) - Liquid biopsy company Angle PLC on Monday said it has received positive results from a study examining the use of its Parsortix system in prenatal testing.Shares in

Read more
29 Oct 2018 11:08

Angle sees 'highly encouraging' results from prenatal testing

(Sharecast News) - Medical diagnostics outfit Angle is talking to "several interested parties" to commercialise its testing device after a "highly encouraging" trial indicated it could be adapted as a non-invasive prenatal test.

Read more
25 Oct 2018 12:55

Angle Nearing Completion Of Patient Enrolment Breast Cancer Study

LONDON (Alliance News) - Liquid biopsy firm Angle PLC said it is making good progress on recruiting patients for its ANG-002 clinical study.The study is focusing on a treatment for breast a

Read more
25 Oct 2018 08:52

Angle makes 'good progress' with ANG-002 patient enrolment

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that patient enrolment for its ANG-002 FDA clinical study for metastatic breast cancer had continued to make good progress.

Read more
23 Oct 2018 15:59

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 24 OctoberIndigovisionBeeks FinancialReddePhoto-Me 25 & Smart 26 29 30

Read more
28 Aug 2018 14:17

Angle's Parsortix System Able To Identify Tumour Cells In Glioblastoma

LONDON (Alliance News) - Angle PLC on Tuesday said researchers at the Cancer Metastasis Laboratory, located at the University of Basel, have provided evidence of circulating tumour cell clusters a

Read more
14 May 2018 12:17

ANGLE Appoints Urological Surgeon Greg Shaw As Scientific Advisor

LONDON (Alliance News) - ANGLE PLC said Monday it appointed urological surgeon, Greg Shaw, as a scientific advisor.The liquid biopsy company appointed the prostate cancer UK National Health

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.